Pathogenesis of membranous nephropathy: Recent advances and future challenges

Nature Reviews Nephrology

Volumn 8, Issue 4, 2012, Pages 203-213

  Ronco, Pierre ^a   Debiec, Hanna ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIGEN; BOVINE SERUM ALBUMIN; CORTICOTROPIN; HLA DQA1 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MELANOCORTIN RECEPTOR AGONIST; PODOCYTE ANTIGEN; PROTEINASE; SECRETORY PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; BIOLOGICAL MONITORING; COMPLEMENT ACTIVATION; DIAGNOSTIC TEST; DRUG MECHANISM; GENE LOCUS; GENETIC ASSOCIATION; HEYMANN NEPHRITIS; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; IMMUNE RESPONSE; MEMBRANOUS GLOMERULONEPHRITIS; NEWBORN DISEASE; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SERUM SICKNESS;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; GLOMERULONEPHRITIS, MEMBRANOUS; HLA-DQ ALPHA-CHAINS; HUMANS; NEPRILYSIN; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84859007767     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.35     Document Type: Review

References (122)

1. Glassock, R. J. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am. J. Kidney Dis. 56, 157-167 (2010).
2. Kerjaschki, D. Pathogenetic concepts of membranous glomerulopathy (MGN). J. Nephrol. 13 (Suppl. 3), S96-S100 (2000).
3. Imai, H., Hamai, K., Komatsuda, A., Ohtani, H. & Miura, A. B. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 51, 270-276 (1997).
4. Kuroki, A. et al. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern. Med. 41, 936-942 (2002).
5. Ohtani, H. et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol. Dial. Transplant. 19, 574-579 (2004).
6. Segawa, Y. et al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr. Nephrol. 25, 1091-1099 (2010).
7. Ponticelli, C. Membranous nephropathy. J. Nephrol. 20, 268-287 (2007).
8. Polanco, N. et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J. Am. Soc. Nephrol. 21, 697-704 (2010).
9. Polanco, N. et al. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol. Dial. Transplant. 27, 231-234 (2012).
10. Glassock, R. J. Diagnosis and natural course of membranous nephropathy. Semin. Nephrol. 23, 324-332 (2003).
11. Cattran, D. Management of membranous nephropathy: when and what for treatment. J. Am. Soc. Nephrol. 16, 1188-1194 (2005).
12. Glassock, R. J. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum? Am. J. Kidney Dis. 44, 562-566 (2004).
13. Waldman, M. & Austin, H. A. III. Controversies in the treatment of idiopathic membranous nephropathy. Nat. Rev. Nephrol. 5, 469-479 (2009).
14. Cattran, D. C., Reich, H. N., Kim, S. J. & Troyanov, S. Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy. Clin. J. Am. Soc. Nephrol. 6, 1591-1598 (2011).
15. Heymann, W., Hackel, D. B., Harwood, S., Wilson, S. G. & Hunter, J. L. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc. Soc. Exp. Biol. Med. 100, 660-664 (1959).
16. Van Damme, B. J., Fleuren, G. J., Bakker, W. W., Vernier, R. L. & Hoedemaeker, P. J. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab. Invest. 38, 502-510 (1978).
17. Couser, W. G., Steinmuller, D. R., Stilmant, M. M., Salant, D. J. & Lowenstein, L. M. Experimental glomerulonephritis in the isolated perfused rat kidney. J. Clin. Invest. 62, 1275-1287 (1978).
18. Border, W. A., Ward, H. J., Kamil, E. S. & Cohen, A. H. Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J. Clin. Invest. 69, 451-461 (1982).
19. Adler, S. G., Wang, H., Ward, H. J., Cohen, A. H. & Border, W. A. Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. J. Clin. Invest. 71, 487-499 (1983).
20. Kerjaschki, D. & Farquhar, M. G. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc. Natl Acad. Sci. USA 79, 5557-5561 (1982).
21. Kerjaschki, D. & Farquhar, M. G. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J. Exp. Med. 157, 667-686 (1983).
22. Debiec, H. et al. Early childhood membranous nephropathy due to cationic bovine serum albumin. N. Engl. J. Med. 364, 2101-2110 (2011).
23. Debiec, H. et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N. Engl. J. Med. 346, 2053-2060 (2002).
24. Debiec, H. et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 364, 1252-1259 (2004).
25. 2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11-21 (2009).
26. 2R1 alleles in idiopathic membranous nephropathy. N. Engl. J. Med. 364, 616-626 (2011).
27. Prunotto, M. et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J. Am. Soc. Nephrol. 21, 507-519 (2010).
28. Bruschi, M. et al. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens. J. Proteomics 74, 2008-2017 (2011).
29. Couser, W. G. & Salant, D. J. In situ immune complex formation and glomerular injury. Kidney Int. 17, 1-13 (1980).
30. Dixon, F. J., Feldman, J. D. & Vazquez, J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J. Exp. Med. 113, 899-920 (1961).
31. Wilson, C. B. & Dixon, F. J. Quantitation of acute and chronic serum sickness in the rabbit. J. Exp. Med. 134, 7-18 (1971).
32. Saito, A. et al. Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis. Proc. Natl Acad. Sci. USA 93, 8601-8605 (1996).
33. Yamazaki, H. et al. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis. J. Am. Soc. Nephrol. 9, 1638-1644 (1998).
34. Allegri, L. et al. Polyvalent antigen-antibody interactions are required for the formation of electron-dense immune deposits in passive Heymann's nephritis. Am. J. Pathol. 125, 1-6 (1986).
35. Raychowdhury, R., Zheng, G., Brown, D. & McCluskey, R. T. Induction of Heymann nephritis with a gp330/megalin fusion protein. Am. J. Pathol. 148, 1613-1623 (1996).
36. Oleinikov, A. V., Feliz, B. J. & Makker, S. P. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease. J. Am. Soc. Nephrol. 11, 57-64 (2000).
37. Tramontano, A. & Makker, S. P. Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis. J. Immunol. 172, 2367-2373 (2004).
38. Tramontano, A., Knight, T., Vizzuso, D. & Makker, S. P. Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis. J. Am. Soc. Nephrol. 17, 1979-1985 (2006).
39. Shah, P., Tramontano, A. & Makker, S. P. Intramolecular epitope spreading in Heymann nephritis. J. Am. Soc. Nephrol. 18, 3060-3066 (2007).
40. Ronco, P. et al. A monoclonal antibody to brush border and passive Heymann nephritis. Clin. Exp. Immunol. 55, 319-332 (1984).
41. Assmann, K. J., Tangelder, M. M., Lange, W. P., Tadema, T. M. & Koene, R. A. Membranous glomerulonephritis in the mouse. Kidney Int. 24, 303-312 (1983).
42. Assmann, K. J. et al. Comparison of antigenic targets involved in antibody-mediated membranous glomerulonephritis in the mouse and rat. Am. J. Pathol. 121, 112-122 (1985).
43. Assmann, K. J. et al. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse. Lab. Invest. 60, 138-146 (1989).
44. Meyer, T. N. et al. A new mouse model of immune-mediated podocyte injury. Kidney Int. 72, 841-852 (2007).
45. Meyer-Schwesinger, C. et al. Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis. J. Immunol. 187, 3218-3229 (2011).
46. Cybulsky, A. V., Quigg, R. J. & Salant, D. J. Experimental membranous nephropathy redux. Am. J. Physiol. Renal Physiol. 289, F660-F671 (2005).
47. Nangaku, M., Shankland, S. J. & Couser, W. G. Cellular response to injury in membranous nephropathy. J. Am. Soc. Nephrol. 16, 1195-1204 (2005).
48. Cunningham, P. N. & Quigg, R. J. Contrasting roles of complement activation and its regulation in membranous nephropathy. J. Am. Soc. Nephrol. 16, 1214-1222 (2005).
49. Koyama, A., Inage, H., Kobayashi, M., Narita, M. & Tojo, S. Effect of chemical cationization of antigen on glomerular localization of immune complexes in active models of serum sickness nephritis in rabbits. Immunology 58, 529-534 (1986).
50. Bass, P. S., Drake, A. F., Wang, Y., Thomas, J. H. & Davies, D. R. Cationization of bovine serum albumin alters its conformation as well as its charge. Lab. Invest. 62, 185-188 (1990).
51. Wright, N. G., Mohammed, N. A., Eckersall, P. D. & Nash, A. S. Experimental immune complex glomerulonephritis in dogs receiving cationized bovine serum albumin. Res. Vet. Sci. 38, 322-328 (1985).
52. Koyama, A. et al. Role of antigenic charge and antibody avidity on the glomerular immune complex localization in serum sickness of mice. Clin. Exp. Immunol. 64, 606-614 (1986).
53. Chen, J. S. et al. Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol. Dial. Transplant. 19, 2721-2728 (2004).
54. Wu, C. C. et al. Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy. Kidney Int. 72, 831-840 (2007).
55. Urizar, R. E., Cerda, J. & Reilly, A. Glomerulitis induced by cationized bovine serum albumin in the rat. Pediatr. Nephrol. 3, 149-155 (1989).
56. Schmiedeke, T. M. et al. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J. Exp. Med. 169, 1879-1894 (1989).
57. Termaat, R. M. et al. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int. 42, 1363-1371 (1992).
58. Matsuo, S. et al. Experimental glomerulonephritis induced in rats by a lectin and its antibodies. Kidney Int. 36, 1011-1021 (1989).
59. Iskandar, S. S., Zhang, J. M. & Rodriguez, E. Nephropathy induced in a nephritis-resistant inbred mouse strain with the use of a cationized antigen. Am. J. Pathol. 123, 67-72 (1986).
60. Ronco, P. & Debiec, H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J. Am. Soc. Nephrol. 16, 1205-1213 (2005).
61. Stahl, R., Hoxha, E. & Fechner, K. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N. Engl. J. Med. 363, 496-498 (2010).
62. 2 receptor in recurrent and de novo membranous nephropathy. Am. J. Transplant. 11, 2144-2152 (2011).
63. East, L. & Isacke, C. M. The mannose receptor family. Biochim. Biophys. Acta 1572, 364-386 (2002).
64. West, A. P. Jr, Herr, A. B. & Bjorkman, P. J. The chicken yolk sac IgY receptor, a functional equivalent of the mammalian MHC-related Fc receptor, is a phospholipase A2 receptor homolog. Immunity 20, 601-610 (2004).
65. Llorca, O. Extended and bent conformations of the mannose receptor family. Cell. Mol. Life Sci. 65, 1302-1310 (2008).
66. Pedchenko, V. et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N. Engl. J. Med. 363, 343-354 (2010).
67. Pedchenko, V., Vanacore, R. & Hudson, B. Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis. Curr. Opin. Nephrol. Hypertens. 20, 290-296 (2011).
68. Bagchus, W. M., Hoedemaeker, P. J., Vos, J. T. & Bakker, W. W. Thymocytes reacting with heterologous antibodies against GP 330 in autologous immune complex glomerulopathy (AICG) in the rat. The relation between susceptibility for AICG and anti-GP 330-binding thymocytes. Immunobiology 179, 432-444 (1989).
69. Vaughan, R. W., Demaine, A. G. & Welsh, K. I. A DQA1 allele is strongly associated with idiopathic membranous nephropathy. Tissue Antigens 34, 261-269 (1989).
70. Dyer, P. A., Short, C. D., Clarke, E. A. & Mallick, N. P. HLA antigen and gene polymorphisms and haplotypes established by family studies in membranous nephropathy. Nephrol. Dial. Transplant. 7 (Suppl. 1), 42-47 (1992).
71. Berthoux, F. C. et al. Immunogenetics and immunopathology of human primary membranous glomerulonephritis: HLA-A, B, DR antigens; functional activity of splenic macrophage Fc-receptors and peripheral blood T-lymphocyte subpopulations. Clin. Nephrol. 22, 15-20 (1984).
72. Sacks, S. H., Warner, C., Campbell, R. D. & Dunham, I. Molecular mapping of the HLA class II region in HLA-DR3 associated idiopathic membranous nephropathy. Kidney Int. Suppl. 39, S13-S19 (1993).
73. Liu, Y. H. et al. Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan. J. Biomed. Sci. 17, 81-88 (2010).
74. Kim, S. et al. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy. Nephron Clin. Pract. 117, c253-c258 (2011).
75. Bantis, C. et al. Tumor necrosis factor-á gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am. J. Nephrol. 26, 12-15 (2006).
76. Thibaudin, D. et al. TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy. Kidney Int. 71, 431-437 (2007).
77. Honkanen, E., von Willebrand, E., Teppo, A. M., Törnroth, T. & Grönhagen-Riska, C. Adhesion molecules and urinary tumor necrosis factor-α in idiopathic membranous glomerulonephritis. Kidney Int. 53, 909-917 (1998).
78. Neale, T. J. et al. Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am. J. Pathol. 146, 1444-1454 (1995).
79. Tabibzadeh, S. et al. TNF-α induces dyscohesion of epithelial cells. Association with disassembly of actin filaments. Endocrine 3, 549-556 (1995).
80. Huber, T. B. & Benzing, T. The slit diaphragm: a signaling platform to regulate podocyte function. Curr. Opin. Nephrol. Hypertens. 14, 211-216 (2005).
81. Lo, W. Y. et al. Association between genetic polymorphisms of the NPHS1 gene and membranous glomerulonephritis in the Taiwanese population. Clin. Chim. Acta 411, 714-718 (2010).
82. Chen, C. H. et al. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy. Nephrol. Dial. Transplant. 23, 3166-3173 (2008).
83. Chen, S. Y. et al. Association of STAT4 polymorphisms with susceptibility to primary membranous glomerulonephritis and renal failure. Clin. Chim. Acta 412, 1899-1904 (2011).
84. Chen, S. Y. et al. Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population. Ren. Fail. 32, 1172-1176 (2010).
85. Qin, W. et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J. Am. Soc. Nephrol. 22, 1137-1143 (2011).
86. 2 receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am. J. Kidney Dis. 57, 140-143 (2011).
87. 2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol. Dial. Transplant. 26, 2526-2532 (2011).
88. 2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 6, 1286-1291 (2011).
89. Beck, L. H. Jr & Salant, D. J. Membranous nephropathy: recent travels and new roads ahead. Kidney Int. 77, 765-770 (2010).
90. Beck, L. H. Jr et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J. Am. Soc. Nephrol. 22, 1543-1550 (2011).
91. 2R glomerular deposits in membranous nephropathy. N. Engl. J. Med. 364, 689-690 (2011).
92. Zhang, M. et al. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203, 141-152 (2006).
93. Herrera, O. B. et al. A novel pathway of alloantigen presentation by dendritic cells. J. Immunol. 173, 4828-4837 (2004).
94. Terrier, B. et al. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun. Rev. 6, 176-182 (2007).
95. Servettaz, A. et al. Identification of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach. Proteomics 8, 1000-1008 (2008).
96. Jordan, S. C., Buckingham, B., Sakai, R. & Olson, D. Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N. Engl. J. Med. 304, 1212-1215 (1981).
97. Takekoshi, Y. et al. Free "small" and IgG-associated "large" hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N. Engl. J. Med. 300, 814-819 (1979).
98. Hörl, W. H. & Kerjaschki, D. Membranous glomerulonephritis (MGN). J. Nephrol. 13, 291-316 (2000).
99. Kain, R. et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat. Med. 14, 1088-1096 (2008).
100. Lundberg, K. & Venables, P. J. Epitope spreading in animal models: array of hope in rheumatoid arthritis and multiple sclerosis. Arthritis Res. Ther. 10, 122 (2008).
101. Chen, L. et al. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J. Am. Soc. Nephrol. 17, 3076-3081 (2006).
102. Tipping, P. G. & Kitching, A. R. Glomerulonephritis, Th1 and Th2: what's new? Clin. Exp. Immunol. 142, 207-215 (2005).
103. Kuroki, A., Iyoda, M., Shibata, T. & Sugisaki, T. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int. 68, 302-310 (2005).
104. van der Zee, J. S., van Swieten, P. & Aalberse, R. C. Inhibition of complement activation by IgG4 antibodies. Clin. Exp. Immunol. 64, 415-422 (1986).
105. Aalberse, R. C. & Schuurman, J. IgG4 breaking the rules. Immunology 105, 9-19 (2002).
106. Lhotta, K., Würzner, R. & König, P. Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrol. Dial. Transplant. 14, 881-886 (1999).
107. Spicer, S. T. et al. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats. J. Immunol. 179, 172-178 (2007).
108. Leenaerts, P. L., Hall, B. M., Van Damme, B. J., Daha, M. R. & Vanrenterghem, Y. F. Active Heymann nephritis in complement component C6 deficient rats. Kidney Int. 47, 1604-1614 (1995).
109. Kerjaschki, D. et al. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. J. Clin. Invest. 100, 2303-2309 (1997).
110. Lambeau, G. & Gelb, M. H. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu. Rev. Biochem. 77, 495-520 (2008).
111. Hanasaki, K. & Arita, H. Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. Prostaglandins Other Lipid Mediat. 68-69, 71-82 (2002).
112. 2 activation in experimental membranous nephropathy. Kidney Int. 57, 1052-1062 (2000).
113. 2. J. Biol. Chem. 271, 250-257 (1996).
114. Augert, A. et al. The M-type receptor PLA2R regulates senescence through the p53 pathway. EMBO Rep. 10, 271-277 (2009).
115. Sis, B. et al. Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int. 71, 218-226 (2007).
116. Berg, A. L., Nilsson-Ehle, P. & Arnadottir, M. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int. 56, 1534-1543 (1999).
117. Bomback, A. S. et al. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel. Drug Des. Devel. Ther. 5, 147-153 (2011).
118. Mountjoy, K. G., Robbins, L. S., Mortrud, M. T. & Cone, R. D. The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251 (1992).
119. Lindskog, A. et al. Melanocortin 1 receptor agonists reduce proteinuria. J. Am. Soc. Nephrol. 21, 1290-1298 (2010).
120. Nortier, J. L. et al. Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoring. Pediatr. Nephrol. 21, 1399-1405 (2006).
121. Atkinson, C., Qiao, F., Song, H., Gilkeson, G. S. & Tomlinson, S. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. J. Immunol. 180, 1231-1238 (2008).
122. Huang, Y., Qiao, F., Atkinson, C., Holers, V. M. & Tomlinson, S. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. J. Immunol. 181, 8068-8076 (2008).